Joshua Brandstadter is an Oncology physician affiliated with University of Pennsylvania. OpenAlex indexes 48 publications with 870 citations (h-index 12); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Ruxolitinib in Previously Treated Idiopathic Multicentric Castleman Disease
Sponsor: University of Pennsylvania
- Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease
Sponsor: University of Pennsylvania
- International Registry for Patients With Castleman Disease
Sponsor: University of Pennsylvania
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- RECORDATI_RARE_DISEASES_INC.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2025–2026 per NIH RePORTER. The latest:
- ACCELERATE: An Efficient and Innovative Natural History Study Addressing Unmet Needs in Castleman Disease
University of Pennsylvania
FY2026$600,000R01FD007632 - Lymph Node Stromal Cells in the Pathogenesis, Diagnosis, and Treatment of Unicentric Castleman Disease
University of Pennsylvania
FY2026$164,860K08HL171943 - ACCELERATE: An Efficient and Innovative Natural History Study Addressing Unmet Needs in Castleman Disease
University of Pennsylvania
FY2025$397,605R01FD007632
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Breast-implant associated unicentric castleman disease: a case report
Current Problems in Cancer Case Reports
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Carl June, MD
University of Pennsylvania
Raquel Gur, MD
University of Pennsylvania
Howard Herrmann, MD
University of Pennsylvania
Robert Vonderheide, MD
University of Pennsylvania
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Beth Karlan, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”